Abstract
Genetically haploidentical stem cell transplants have been performed for several decades, mostly for patients with advanced acute leukemia. Such transplants are an option for those patients who do not have a histocompatible sibling donor. The historical data have been disappointing due to graft-versus-host disease, engraftment failure and delayed immune reconstitution. Recent modifications and new technological developments have led to more encouraging clinical results. Haploidentical transplantation is immediately available to the majority of patients with acute leukemia and is an acceptable alternative to matched unrelated donor transplantation. Bone Marrow Transplantation (2001) 27, 669–676.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Petersdorf EW, Gooley T, Anasetti C et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient Blood 1998 92: 3515–3520
Sasazuki T, Juji T, Morishima Y et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor New Engl J Med 1998 339: 1177–1185
Lamparelli T, Van Lint MT, Gualandi F et al. Bone marrow transplantation for chronic myeloid leukemia from unrelated and sibling donors: single center experience Bone Marrow Transplant 1997 20: 1057–1062
Beatty PG, Clift RA, Mickelson EM et al. Marrow transplantation from related donors other than HLA-identical siblings New Engl J Med 1985 313: 765–771
Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma New Engl J Med 1989 320: 197–204
Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ . Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic lymphocytes Transplantation 1987 43: 842–847
Soiffer RJ, Mauch P, Tarbell NJ et al. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow Bone Marrow Transplant 1991 7: 23–33
Reisner Y, Ben-Bassat I, Douer D et al. Demonstration for clonable alloreactive host T cells in a primate model for bone marrow transplantation Proc Natl Acad Sci USA 1986 83: 4012–4015
Butturini A, Seeger RC, Gale RP . Recipient immune competent T lymphocytes can survive intensive conditioning for bone marrow transplantation Blood 1986 68: 954–956
Kook H, Goldman F, Padley D et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery Blood 1996 88: 1089–1097
Ochs L, Shu XO, Miller J et al. Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients Blood 1995 10: 3979–3986
Sullivan KM, Mori M, Sanders J et al. Late complications of allogeneic and autologous marrow transplantation Bone Marrow Transplant 1992 10:: (Suppl. 1) 127–134
Fleming DR, Henslee-Downey PJ, Romond EH et al. Allogeneic bone marrow transplantation with T-cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults: a comparative matched cohort study Bone Marrow Transplant 1996 17: 917–922
Powles RL, Morgenstern GR, Kay HE et al. Mismatched family donors for bone marrow transplantation for treatment for acute leukaemia Lancet 1983 i: 612–615
Szydlo R, Goldman JM, Klein JP et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings J Clin Oncol 1997 15: 1767–1777
Henslee-Downey PJ, Abhyankar SH, Parrish RS et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant Blood 1997 89: 3864–3872
Aversa F, Tabilio A, Velardi A et al. Treatment of high risk acute leukemia with T cell-depleted stem cells from related donors with one fully mismatched HLA haplotype New Engl J Med 1998 339: 1186–1193
Guinan EC, Boussiotis VA, Neuberg D et al. Transplantation of anergic histoincompatible bone marrow allograft New Engl J Med 1999 340: 1704–1714
O'Reilly RJ, Collins NH, Kernan N et al. Transplantation of marrow-depleted T cells by soybean lectin agglutination and E-rosette depletion: major histocompatibility complex-related graft resistance in leukemic transplant recipients Transplant Proc 1985 17: 455–456
Ferrara JL, Deeg HJ . Graft-versus-host disease New Engl J Med 1991 324: 667–674
Korngold R, Sprent J . T-cell subsets and graft-versus-host disease Transplantation 1987 44: 335–339
Reisner Y, Kapoor N, Kirkpatrick D et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells Blood 1983 61: 341–348
Mackinnon S, Papadopoulos EB, Carabasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease Blood 1995 86: 1261–1268
Reisner Y, Martelli MF . Transplantation tolerance induced by ‘mega dose’ CD34 + cell transplants Exp Hematol 2000 28: 119–127
Drobyski WR, Ash RC, Casper JT et al. Effect of T-cell depletion as a graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia Blood 1994 83: 1980–1987
Guinan E . Costimulatory Blockade as a Mechanism of Inducing Tolerance in the allograft setting Educational Book of American Society of Hematology 1999 pp 383–388
Champlin R, Ho W, Gajewski J et al. Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation Blood 1990 76: 418–423
Lamb L, Gee A, Parrish R et al. Acute rejection of marrow grafts in patients transplanted from a partially mismatched related donor: clinical and immunologic characteristics Bone Marrow Transplant 1996 17: 1021–1027
Soderling CC, Cong CW, Blazer BR, Vallera DA . A correlation between conditioning and engraftment in recipients of MHC mismatched T cell-depleted murine bone marrow transplants Immunology 1985 135: 941–946
Sondel TM, Bozdech MJ, Trigg ME et al. Additional immunosuppression allows engraftment following HLA-mismatched T cell-depleted bone marrow transplantation for leukemia Transplant Proc 1985 17: 460–462
Champlin RE, Ho WG, Mitsuyasu R et al. Graft failure and leukemia relapse following T lymphocyte-depleted bone marrow transplants: effect of intensification of immunosuppressive conditioning Transplant Proc 1987 19: 2616–2619
Lapidot T, Singer TS, Reisner Y . Transient engraftment of T cell depleted allogeneic bone marrow in mice improves survival rate following lethal irradiation Bone Marrow Transplant 1988 3: 157–164
Lapidot T, Terenzi A, Singer TS et al. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts Blood 1989 73: 2025–2032
Terenzi A, Lubin I, Lapidot T et al. Enhancement of T-cell depleted bone marrow allografts in mice by thiotepa Transplantation 1990 50: 717–720
Godder K, Pati AR, Abhyankar S et al. Partially mismatched related donor transplants as salvage therapy for patients with refractory leukemia who relapse post-BMT Bone Marrow Transplant 1996 17: 49–53
Kernan NA, Emanuel D, Castro-Malaspina H et al. Posttransplant immunosuppression with antithymocyte globulin and methylprednisolone prevents immunologically mediated graft failure following a T-cell depleted marrow transplant Blood 1989 74: 123a
Fischer A, Griscelli C, Blanche S et al. Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone marrow transplantation Lancet 1986 ii: 1058–1061
Henslee-Downey PJ, Parrish RS, Macdonald JS et al. Combined ex-vivo and in-vivo T-lymphocyte depletion for the control of graft-versus-host disease following haplo-identical marrow transplant Transplantation 1996 61: 738–745
Malilay GP, Sevenich EA, Condie RM, Filipovich AH . Prevention of graft rejection in allogeneic bone marrow transplantation: I. Preclinical studies with antithymocyte globulins Bone Marrow Transplant 1989 4: 107–112
Henslee-Downey PJ . Allogeneic related partially mismatched transplantation. In: Barrett J, Treleaven J (eds) The Clinical Practice of Stem-Cell Transplantation Isis Medical Media: Oxford 1998 p 391
Henslee-Downey PJ, Godder K, Abhyankar S et al. Sequential immuno-modulation to achieve engraftment and control graft-versus-host disease across mismatched MHC barriers Educational Book of American Society of Hematology 1999 pp 389–394
Reisner Y, Martelli MF . Tolerance induction by ‘megadose’ transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor Curr Opin Immunol 2000 12: 536–541
Rachmim N, Gan J, Segall R et al. Tolerance induction by ‘megadose’ hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocytes culture Transplantation 1998 65: 1386–1393
Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T cell-depleted haploidentical ‘three-loci’ incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood 1994 84: 3948–3955
Reisner Y, Martelli MF . Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells Immunol Today 1995 16: 437–440
Bachar-Lustig E, Rachamim N, Li HW et al. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice Nature Med 1995 1: 1268–1273
Reisner Y, Aversa F, Bachar-Lustig E et al. The role of megadose CD34 haploidentical transplantation: potential application to tolerance induction Educational Book of American Society of Hematology 1999 pp 376–382
Cilloni D, Carlo-Stella C, Falzetti F et al. Limited engraftment T capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation Blood 2000 96: 3637–3643
Lazarus HM, Koc ON . Culture-expanded human marrow-derived mesenchymal stem cell transplantation Graft 2001 (in press
Lamb LS, Szafer F, Henslee-Downey et al. Characterization of acute bone marrow graft rejection in T cell-depleted, partially mismatched related donor bone marrow transplantation Exp Hematol 1995 23: 1595–1600
Lamb LS, Gee AP, Henslee-Downey PJ et al. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors Bone Marrow Transplant 1998 21: 461–471
Roux E, Dumont-Girard F, Starobinski M et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity Blood 2000 96: 2299–2303
Volpi I, Perruccio K, Ruggeri L et al. G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation Blood 1999 10: (Suppl. 1) 2841a
Perruccio K, Tosti A, Posati S et al. Transfer of functional immune responses to aspergillus and CMV after haploidentical hematopoietic transplantation Blood 2000 96: 2383a
Walter EA, Greenberg PD, Gilbert MJ et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor New Engl J Med 1995 333: 1038–1044
Riddell SR, Greenberg PD . Adoptive immunotherapy with antigen-specific T cells. In: Thomas ED, Blume KJ, Forman SJ (eds) Hematopoietic Cell Transplantation Blackwell Science: Oxford 1999 327–341
Cavazzana-Calvo M, Stephan JL, Sarnacki S et al. Attenuation of graft-versus-host disease and graft rejection by ex-vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination Blood 1994 83: 288–298
Boussiotis VA, Gribben JG, Freeman EJ, Nadler LM . Blockade of the CD 28 co-stimulatory pathway: a means to induce tolerance Curr Opin Immunol 1994 6: 797–807
Gribben JG, Guinan EC, Boussiotis VA et al. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool Blood 1996 87: 4887–4893
Sambhara SR, Miller RG . Programmed cell death of T cells signaled by the T-cell receptor and the a3 domain of class I MHC Science 1991 252: 1424–1427
Reisner Y, Bachar-Lustig E, Li HW et al. Purified Sca-1+Lin-stem cells can tolerize fully allogeneic host T cells remaining after sublethal TBI Blood 1997 90: 563a
Bachar-Lustig E, Li HW, Marcus H, Reisner Y . Tolerance induction of megadose stem cell transplants: synergism between Sca-1+Lin cells and non-alloreactive T-cells Transplant Proc 1998 30: 4007–4008
Bachar-Lustig E, Li HW, Gur H et al. Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca-1 (+)Lin (−) bone marrow progenitor cells: synergism with non-alloreactive (Host × donor)F (1) T cells Blood 1999 94: 3212–3221
Lee LA, Sergio JJ, Sykes M . Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells Transplantation 1996 61: 125–132
Ruggeri L, Capanni M, Casucci M et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood 1999 94: 333–339
Ruggeri L, Capanni M, Urbani E et al. KIR epitope incompatibility in their GvH direction predicts control of leukemia relapse after mismatched hematopoietic transplantation Blood 2000 96: 2059a
Davies SM, Kollman C, Anasetti C et al. Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the National Marrow Donor Program Blood 2000 96: 4096–4102
McGlave PB, Shu XO, Wen W et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 year's experience of the national marrow donor program Blood 2000 95: 2219–2225
Anasetti C . Transplantation of hematopoietic stem cells from alternate donors in acute myelogenous leukemia Leukemia 2000 14: 502–504
Sierra J, Storer B, Hansen JA et al. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience Bone Marrow Transplant 2000 26: 397–404
Aversa F, Martelli MF . Haploidentical stem cell transplantation in leukemia Blood Rev 2001 (in press).
Aversa F, Tabilio A, Velardi A et al. Advances in full-haplotype mismatched transplants in acute leukemia Blood 1999 94: (Suppl. 1) 2522a
Bunjes D, Duncker C, Wiesneth M et al. CD34+ selected cells in mismatched stem cell transplantation: a single centre experience of haploidentical peripheral blood stem cell transplantation Bone Marrow Transplant 2000 25: (Suppl. 2) 9–11
Passweg JR, Kuhne T, Gregor M et al. Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplants Bone Marrow Transplant 2000 26: 1033–1036
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rowe, J., Lazarus, H. Genetically haploidentical stem cell transplantation for acute leukemia. Bone Marrow Transplant 27, 669–676 (2001). https://doi.org/10.1038/sj.bmt.1702856
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702856
Keywords
This article is cited by
-
Development of simple and rapid HLA-C genotyping method using an oligonucleotide microarray
BioChip Journal (2011)
-
Transplantation CD3/CD19-depletierter Stammzellen
Monatsschrift Kinderheilkunde (2010)
-
Use of natural killer cells in hematopoetic stem cell transplantation
Bone Marrow Transplantation (2005)
-
Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation
Bone Marrow Transplantation (2005)
-
Immune restoration following hematopoietic stem cell transplantation: an evolving target
Bone Marrow Transplantation (2005)